Stock Screener App

무료 -

설치하다

63.21

1.51% 0.82

Cytokinetics Inc (CYTK)

개요 뉴스 가격 이력 옵션 체인 Financials CYTK 왜 하락? 토론 예측 주식 분할

Cytokinetics Inc 주식(CYTK)의 최신 뉴스

Spinal Muscular Atrophy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Genentech, Chugai Pharma, Cytokinetics, Ionis Pharma, Genzyme Corp - Barchart.com

Cytokinetics Inc (HAM:KK3A) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Aug Catalysts: What is the long term forecast for Cytokinetics Incorporated stockShort Setup & High Accuracy Trade Alerts - baoquankhu1.vn

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cytokinetics, Incorporated (CYTK) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

E. Ohman J or Asset Management AB Has $23.06 Million Stock Holdings in Cytokinetics, Incorporated $CYTK - MarketBeat

Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential - The Motley Fool

Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

2026-03-22 | Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:CYTK | Press Release - Stockhouse

Cytokinetics, Incorporated $CYTK Shares Bought by Hudson Bay Capital Management LP - MarketBeat

Cytokinetics (CYTK) EVP sells 1,930 shares, retaining over 78,000 - Stock Titan

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cytokinetics, Incorporated (CYTK) And Encourages Investors to Connect - ACCESS Newswire

Insider Sell: Andrew Callos Sells Shares of Cytokinetics Inc (CY - GuruFocus

Sung Lee Sells 4,935 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat

Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 1,930 Shares of Stock - MarketBeat

Malik Fady Ibraham sells Cytokinetics (CYTK) stock worth $747,850 By Investing.com - Investing.com Canada

Blum, Cytokinetics CEO, sells $2.2m in shares By Investing.com - Investing.com Canada

Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 36,601 Shares of Stock - MarketBeat

Fady Ibraham Malik Sells 12,033 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat

Andrew Callos Sells 8,542 Shares of Cytokinetics (NASDAQ:CYTK) Stock - MarketBeat

Malik Fady Ibraham sells Cytokinetics (CYTK) stock worth $747,850 - Investing.com

Cytokinetics Insiders Sold Shares Worth Over $3.6M - TradingView

Cytokinetics (CYTK) CFO share sale covers RSU tax obligations - Stock Titan

Mizuho Raises Price Target for Cytokinetics (CYTK) to $100 | CYT - GuruFocus

Cytokinetics (CYTK) EVP executes 8,542-share sell-to-cover for RSU taxes - Stock Titan

[Form 4] CYTOKINETICS INC Insider Trading Activity - Stock Titan

Cytokinetics President & CEO Sold Shares Worth Over $2.2M - TradingView

Cytokinetics (CYTK) CEO executes sell-to-cover stock sales for taxes - Stock Titan

Andrew Callos reports multiple 10b5-1 sales for CYTK (NASDAQ: CYTK) - Stock Titan

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Mizuho Boosts Cytokinetics (NASDAQ:CYTK) Price Target to $100.00 - MarketBeat

Cytokinetics Q4 2025 earnings preview - MSN

New Aficamten HCM Data On Exercise Capacity And Flexibility Might Change The Case For Investing In Cytokinetics (CYTK) - simplywall.st

Cytokinetics (CYTK) CEO receives new RSU and stock option awards - Stock Titan

Bronstein, Gewirtz & Grossman, LLC Encourages Cytokinetics, Incorporated (CYTK) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Cytokinetics (CYTK) EVP awarded new stock options and RSUs - Stock Titan

Cytokinetics (CYTK) awards stock options and RSUs to chief legal officer - Stock Titan

Cytokinetics (CYTK) CFO granted RSUs and stock options - Stock Titan

[Form 4] CYTOKINETICS INC Insider Tradi... - Stock Titan

JPMorgan Chase & Co. Raises Cytokinetics (NASDAQ:CYTK) Price Target to $75.00 - MarketBeat

CYTK Analyst Update: JP Morgan Raises Price Target to $75 | CYTK Stock News - GuruFocus

Cytokinetics stock price target raised to $75 by JPMorgan - Investing.com Canada

JPMorgan Boosts Price Target on Cytokinetics (CYTK) Amid Positiv - GuruFocus

Granahan Investment Management LLC Purchases Shares of 53,550 Cytokinetics, Incorporated $CYTK - MarketBeat

Bamco Inc. NY Makes New Investment in Cytokinetics, Incorporated $CYTK - National Today

Cytokinetics MYQORZO Data Sheds Light On oHCM Outlook And Valuation - simplywall.st

Assessing Cytokinetics (CYTK) Valuation After New MYQORZO Trial Data And Safety Outcomes - Yahoo Finance

Cytokinetics (NASDAQ:CYTK) EVP Sells $104,300.27 in Stock - MarketBeat

Stifel reiterates Cytokinetics stock rating ahead of trial data By Investing.com - Investing.com Canada

Andrew Callos 10b5-1 sales reported for CYTK (NASDAQ: CYTK) - Stock Titan

Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market - AOL.com

Cytokinetics (CYTK) Presents Findings on Aficamten for Cardiomyo - GuruFocus

Cytokinetics announces four presentations at the American College of Cardiology annual scientific session & expo - marketscreener.com

Cytokinetics Announces Four Presentations At The American College Of Cardiology Annual Scientific Session & Expo - TradingView

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual ... - nrtoday.com

Heart drug MYQORZO outperforms beta blocker in key HCM studies - Stock Titan

HighVista Strategies LLC Acquires 64,278 Shares of Cytokinetics, Incorporated $CYTK - MarketBeat

458,295 Shares in Cytokinetics, Incorporated $CYTK Purchased by Foresite Capital Management IV LLC - MarketBeat

Cinctive Capital Management LP Takes Position in Cytokinetics, Incorporated $CYTK - MarketBeat

Cytokinetics, Incorporated $CYTK Shares Acquired by Aquatic Capital Management LLC - MarketBeat

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo - Yahoo Finance

Boxer Capital Management LLC Acquires New Shares in Cytokinetics, Incorporated $CYTK - MarketBeat

Checkpoint Capital L.P. Invests $2.07 Million in Cytokinetics, Incorporated $CYTK - MarketBeat

Cytokinetics Highlights Early MYQORZO Momentum, Eyes Q2 nHCM Phase 3 Catalyst at Barclays Confab - MarketBeat

ROIV

$26.98

0.99%

RPRX

$47.05

3.03%

MRNA

$52.97

3.11%

BNTX

$88.06

0.83%

ONC

$272.99

1.11%

INSM

$146.63

6.51%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개